Skip to main content
Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes With Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan
Keira Smith
Expert Analysis
Oncology Data Advisor® · Kidney Cancer Awareness Month: Discovering Clinical Strategies to Improve Outcomes In this edition of Oncology Data Advisor celebrating Kidney Cancer Awareness Month Dr. Samuel Kareff, Dr. Waqas Haque, and Dr. Ulka Vaishampayan discuss the rising incidence of kidney cancer, warning signs and symptoms to look out for, environmental risk factors such as tobacco use, emerging treatment strategies using immunotherapy and adjuvant therapy, considerations for genetic testing, and the importance of clinical trial participation for bringing these new advances to the forefront of care. 
Kidney Cancer Awareness Month: Spotlight on Genetic Counseling With Hiam Abdel-Salam, MS, CGC, and Donika Saporito, MS
Keira Smith
Expert Analysis
Oncology Data Advisor® · Kidney Cancer Awareness Month: Spotlight on Genetic Counseling In this interview for Kidney Cancer Awareness Month, Hiam Abdel-Salam, MS, CGC, speaks with Donika Saporito, MS, a Certified Genetic Counselor in the Genitourinary Center at MD Anderson Cancer Center, who provides an overview of genetic testing for hereditary kidney cancer syndromes and how she personally counsels the patients she sees.  
National Cancer Prevention Month: Lowering Prostate Cancer Risk With Stephen Freedland, MD, and William Aronson, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · National Cancer Prevention Month With Stephen Freedland and William Aronson In honor of National Cancer Prevention Month, Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, sat down with Dr. William Aronson, Professor of Urology at the University of C...
Exploring the TALAPRO-2 Study of Talazoparib and Enzalutamide in Prostate Cancer: Stephen Freedland, MD, and Neeraj Agarwal, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · TALAPRO-2 (Talazoparib + Enzalutamide) in Prostate Cancer: Stephen Freedland and Neeraj Agarwal In this interview, Oncology Data Advisor Editorial Board member Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, speaks with Dr. Neeraj Agarwal, Director of the Genitourinary (GU) Medical Oncology Group at Huntsman Cancer Institute, about his recent publication of the TALAPRO-2 study. Dr. Agarwal delves into the results of the trial, which investigated the efficacy of talazoparib plus enzalutamide for first-line metastatic castration-resistant prostate cancer (mCRPC), and their practice-changing significance. 
Enzalutamide Approved for Nonmetastatic Castration-Sensitive Prostate Cancer With Biochemical Recurrence: Stephen Freedland, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Enzalutamide Approved for Nonmetastatic CSPC With Biochemical Recurrence: Stephen Freedland, MD The FDA recently granted approval to enzalutamide (enza) for the treatment of nonmetastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence, based on the results of the phase 3 EMBARK trial. Following the approval, Oncology Data Advisor Editorial Board member Dr. Stephen Freedland, co-lead investigator of the trial, sat down to share more about its significance for patients with high-risk prostate cancer and biochemical recurrence.
Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD
Lyn Brook
Expert Analysis
Oncology Data Advisor® · Additional Advances in Advanced Prostate Cancer With Tanya Dorff, MD Recently, Tanya Dorff, MD, Division Chief of the Genitourinary Disease Program at City of Hope, served as faculty for i3 Health's CME/NCPD-approved activity, Evolving Treatment Concepts and New Data in Advanced Prostate Cancer. Since recording, ...
Great American Smokeout: The Link Between Smoking and Prostate Cancer With Stephen Freedland, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Great American Smokeout: The Link Between Smoking and Prostate Cancer With Stephen Freedland, MD In honor of the Great American Smokeout, Oncology Data Advisor sat down with Stephen Freedland, MD, the Director of the Center for Integrated Research in Cancer and Lifestyle at Cedars-Sinai Medical Center, to discuss the impact that smoking has on prostate cancer, as well as to help raise awareness around smoking and share resources for those who are trying to quit.  
Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles, MD, MBBS, MRCP
Keira Smith
Expert Analysis
Oncology Data Advisor® · Enfortumab Vedotin Plus Pembrolizumab: Results of the EV-302 Trial With Thomas Powles In this interview, Thomas Powles, MD, MBBS, MRCP, Director of the Barts Cancer Center in London, sat down with Oncology Data Advisor to discuss the results of the EV-302 trial, a phase 3, open-label investigation of enfortumab v...
Prostate Cancer Awareness Month With Ulka Vaishampayan, MD
Lyn Brook
Expert Analysis
Oncology Data Advisor® · Prostate Cancer Awareness Month With Ulka Vaishampayan, MD In honor of Prostate Cancer Awareness Month, Oncology Data Advisor Editorial Board Member Ulka Vaishampayan, Professor of Internal Medicine at the University of Michigan Rogel Cancer Center, sat down to discuss the importance of bringing awareness to pros...
Raising Awareness of Prostate Cancer in Transgender Women With Farnoosh Nik-Ahd, MD, and Stephen Freedland, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Raising Awareness of Prostate Cancer in Transgender Women: Farnoosh Nik-Ahd and Stephen Freedland This interview in honor of Prostate Cancer Awareness Month features Dr. Stephen Freedland, Urologist at Cedars-Sinai Medical Center and Oncology Data Advisor Editorial Board Member, and Dr. Farnoosh Nik-Ahd, Urology Resident at the University of California, San Francisco (UCSF), discussing the risks and incidence of prostate cancer in transgender women. Dr. Nik-Ahd shares the inspiration for her recent first-author study, Prostate Cancer Is Not Just a Man's Concern, the results that she and her team found, and their implications for prostate cancer screening and diagnosis standards for transgender women.  
Metastatic Castration-Sensitive Prostate Cancer: Real-World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD
Keira Smith
Expert Analysis
Oncology Data Advisor® · mCSPC: Real World Characteristics and Treatment by Disease Volume With Stephen Freedland, MD At the recent American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Stephen Freedland, Professor of Urology at Cedars-Sinai Medical Center, sat down with Oncology Data Advisor to discuss his abstract regarding ...
Molecular Analyses of Sacituzumab Govitecan in Urothelial Carcinoma With Manoj Bupathi, MD
Lyn Brook
Expert Analysis
Oncology Data Advisor® · Molecular Analyses of Sacituzumab Govitecan in Urothelial Carcinoma With Manoj Bupathi, MD At the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Manojkumar Bupathi, MD, MS, a Genitourinary (GU) Medical Oncologist at Sarah Cannon Research Institute and Rocky M...
Renal Cell Carcinoma Research and Shared Decision Making With Bradley McGregor, MD
Lyn Brook
Expert Analysis
Oncology Data Advisor® · Renal Cell Carcinoma Research and Shared Decision Making With Bradley McGregor, MD At the recent 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Oncology Data Advisor® sat down with Bradley McGregor, MD, Director of Clinical Research for the Lank Center of Genitourinary Oncology at th...
Additional Advances in Castration-Resistant Prostate Cancer Research With Kathleen Burns, MSN, NP
Lyn Brook
Expert Analysis
Oncology Data Advisor® · Additional Advances in Castration-Resistant Prostate Cancer Research: Kathleen Burns, MSN, NP At the 48th Annual Oncology Nursing Society (ONS) Congress, Kathy Burns, a Nurse Practitioner at City of Hope Comprehensive Cancer Center, sat down with Oncology Data Advisor® to discuss her presentation regarding the ed...
Incorporating Patient-Reported Outcomes Into Prostate Cancer Treatment With Lisa Gudenkauf, PhD
Keira Smith
Expert Analysis
Oncology Data Advisor® · Incorporating Patient-Reported Outcomes Into Prostate Cancer Treatment With Lisa Gudenkauf, PhD At the recent American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, Dr. Lisa Gudenkauf, an Applied Research Scientist at Moffitt Cancer Center, presented her team's research regarding the Functional Assessment of Cancer Therapy—Radionuclide Therapy (FACT-RNT), a novel patient-reported outcomes (PRO) measure for patients with prostate cancer. In this follow-up interview, Dr. Gudenkauf shares more about how the measure was developed, its importance for capturing the patient experience, and its future implementation into both clinical practice and trials.  
Personalizing Prostate Cancer Therapy With Christopher Iannuzzi, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Personalizing Prostate Cancer Therapy With Christopher Iannuzzi, MD In this interview, Oncology Data Advisor speaks with Dr. Christopher Iannuzzi of Hartford HealthCare about an ongoing clinical trial investigating the personalization of prostate cancer treatment through genomic tumor testing. In addition, Dr. Iannuzzi shares the advantages of delivering stereotactic body radiation therapy and the importance of undergoing prostate cancer screening.  
Taking a Nuanced Approach to Testicular Cancer Management With Sam Kaffenberger, MD
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Taking a Nuanced Approach to Testicular Cancer Management With Sam Kaffenberger, MD For this interview in honor of Testicular Cancer Awareness Month, Dr. Sam Kaffenberger, an Assistant Professor of Urology at the University of Michigan Health System, explains the importance of taking a nuanced approach to the m...
Prioritizing Life After Testicular Cancer With Katie Murray, DO
Lyn Brook
Expert Analysis
Oncology Data Advisor™ · Prioritizing Life After Testicular Cancer With Katie Murray, DO For patients with testicular cancer, planning is necessary to ensure that patients feel prepared regarding the implications of their disease in the years after they finish treatment. In this interview in honor of Testicular Cancer Awareness Month, ...
Exploring Recent Advances in Testicular Cancer Surgery and Access to Care With Andrew Winer, MD, FACS
Keira Smith
Expert Analysis
Oncology Data Advisor™ · Exploring Recent Advances in Testicular Cancer Surgery and Access to Care This interview in honor of Testicular Cancer Awareness Month features Dr. Andrew Winer, Chief of Urology at Kings County Hospital in New York. Dr. Winer discusses the ongoing research regarding new approaches for testicular cancer surgery...